Ongoing research aims to improve the efficiency and accuracy of detecting and analyzing circulating fetal cells. Advances in microfluidics and single-cell sequencing technologies hold promise for overcoming current challenges. The ultimate goal is to integrate these cells into routine prenatal screening and diagnostics, offering a safer alternative to invasive methods.
